Drugs

Theravance and Alfa Wassermann Announce Initiation of Phase 2 Study With Velusetrag for Gastroparesis

SOUTH SAN FRANCISCO, CA and BOLOGNA, ITALY: ...

Aptalis Pharma, Inc. Announces Results of Phase 3 Studies of Aeroquin(TM) (Levofloxacin Solution for Inhalation) Among Patients With Cystic Fibrosis and Chronic Lung Infection

BRIDGEWATER, NJ: ...

SciClone Provides Initial 2013 Financial Guidance

FOSTER CITY, CA: ...

Sarepta Therapeutics to Present Company Overview at the 2013 31st Annual JP Morgan Healthcare Conference

CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...

GSK and Theravance Announce Regulatory Submission for UMEC/VI (LAMA/LABA) in the US

LONDON and SOUTH SAN FRANCISCO, CA: ANORO ELLIPTA(TM) Proposed Proprietary Name for UMEC/VI ...

Innate Pharma (Euronext Paris: FR0010331421 - IPH): First Patient Treated in the EffiKIR Trial

MARSEILLE, FRANCE: ...

Cellceutix Enters Into a $10 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

BEVERLY, MA: ...

SciClone to Present at Oppenheimer 23rd Annual Healthcare Conference on December 13th

FOSTER CITY, CA: ...

Parabon NanoLabs Awarded NSF Grant for Development of Cancer Therapeutic With Industry Partner Janssen R&D

RESTON, VA: ...

Enzon Announces Special Dividend

PISCATAWAY, NJ: ...